| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.08 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.08 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |